The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

Big Data, Real World, Multi-State Study Finds RSV Vaccine Highly Effective in Protecting Older Adults Against Severe Disease, Hospitalization and Death Oct. 17, 2024 — This multi-state study is ...

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

The CDC notes that PPSV23 is 60 to 70% effective at protecting people from serious disease caused by the 23 types of pneumococcal bacteria that the vaccine covers. PCV15, PCV20, and PCV21 are ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

LILLE, France, Nov. 12, 2024 /PRNewswire/ -- Today Vaxinano, a biotech company headquartered in Lille (France) announced an ...

Request To Download Free Sample of This Strategic Report @ The publisher has been closely monitoring the various markets in Saudi Arabia Respiratory Disease Vaccine Market. This report provides a ...

New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology platform trigger targeted immune responses Results also showcase the successful design of a proprietary pref ...